Hello. It looks like you’re using an ad blocker that may prevent our website from working properly. To receive the best Tortoise experience possible, please make sure any blockers are switched off and refresh the page.

If you have any questions or need help, let us know at memberhelp@tortoisemedia.com

Friend of Tortoise Exclusive

PTSD in the armed forces: could MDMA be the answer?

PTSD in the armed forces: could MDMA be the answer?

This event is exclusive to Friends of Tortoise

This is a digital-only ThinkIn.

MDMA was originally developed by German scientists more than a century ago. In the 1970s some psychiatrists used the chemical to enhance communication with patients. The practice fell from favour when MDMA became better known as a party drug and the principal ingredient in ecstasy pills. ‘E’s kickstarted the ‘Second Summer of Love’ of 1989 in the UK and MDMA – also known as ‘molly’ –  became intertwined with club culture. Today, psychiatrists are successfully experimenting with therapeutic MDMA as a treatment for Post-Traumatic Stress Disorder (PTSD), with promising trials among US veterans. Last year, General Sir Nick Carter, the outgoing UK Chief of Defence Staff, gave his support to clinical trials of MDMA to treat British soldiers with PTSD. Early signs indicate it could be more effective than talking therapies, and offer thousands of veterans relief from serious mental trauma. 

What kinds of PTSD does it work for, and are there any other banned substances which could be used in treating mental health conditions?  Join us for this ThinkIn with General Sir Nick Carter and other experts and campaigners where we’ll explore how a Class-A recreational drug could become the latest psychiatric treatment. 

editor and invited experts

James Harding
Co-founder and Editor

General Sir Nick Carter
Former Chief of Defence Staff

Gilly Norton
CEO, Support for Wounded Veterans

Rick Doblin
Founder and Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS)